These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6666502)

  • 21. [The usefulness of basal blood glucose and glycosylated hemoglobin for the detection of abnormal glucose tolerance in the relatives of patients with type-2 diabetes mellitus].
    Costa A; Conget I; Treserras R; Gomis R
    Med Clin (Barc); 1999 Feb; 112(7):241-4. PubMed ID: 10220749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
    Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
    Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.
    Narayan KM; Hanson RL; Pettitt DJ; Bennett PH; Knowler WC
    Diabetes Care; 1996 Sep; 19(9):972-8. PubMed ID: 8875091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.
    Motala AA; Omar MA; Gouws E
    Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malondialdehyde (MDA) level in diabetic subjects. Relationship with blood glucose and glycosylated hemoglobin.
    Noberasco G; Odetti P; Boeri D; Maiello M; Adezati L
    Biomed Pharmacother; 1991; 45(4-5):193-6. PubMed ID: 1932603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does familial hypertriglyceridemia predispose to NIDDM?
    Sane T; Taskinen MR
    Diabetes Care; 1993 Nov; 16(11):1494-501. PubMed ID: 8299439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Insulin sensitivity and beta function in the first-degree relatives of type 2 diabetic patients].
    Han XY; Ji LN; Zhou XH
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1777-80. PubMed ID: 15631772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.
    Yang G; Li L; Chen W; Liu H; Boden G; Li K
    Ann Med; 2009; 41(1):52-6. PubMed ID: 18618352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose.
    Liao D; Shofer JB; Boyko EJ; McNeely MJ; Leonetti DL; Kahn SE; Fujimoto WY
    Diabetes Care; 2001 Jan; 24(1):39-44. PubMed ID: 11194238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired glucose tolerance without hypertriglyceridemia does not enhance postprandial lipemia.
    Higashi K; Shige H; Ito T; Nakajima K; Ishikawa T; Nakamura H; Ohsuzu F
    Horm Metab Res; 2001 Feb; 33(2):101-5. PubMed ID: 11294490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of plasma lipid fractions with colorimetrically determined glycated hemoglobin in a nondiabetic population.
    Prat J; Pamplona R; Sorribas A; Martin S; Viñallonga M; Segura R
    Metabolism; 1989 Dec; 38(12):1147-53. PubMed ID: 2593827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosylated hemoglobin and fasting plasma glucose in the assessment of outpatient glycemic control in NIDDM.
    Pecoraro RE; Chen MS; Porte D
    Diabetes Care; 1982; 5(6):592-9. PubMed ID: 6927729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients. A study in Catalonia, a mediterranean community.
    Costa A; Rios M; Casamitjana R; Gomis R; Conget I
    Diabetes Res Clin Pract; 1998 Sep; 41(3):191-6. PubMed ID: 9829348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating lipids and cardiovascular risk in newly diagnosed non-insulin-dependent diabetic subjects in India.
    Shelgikar KM; Naik SS; Khopkar M; Bhat DS; Raut KN; Joglekar CV; Gerard ME; Yajnik CS
    Diabet Med; 1997 Sep; 14(9):757-61. PubMed ID: 9300225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic defects in persistent impaired glucose tolerance are related to the family history of non-insulin-dependent diabetes mellitus.
    Niskanen L; Sarlund H; Laakso M
    Metabolism; 1995 Aug; 44(8):1099-104. PubMed ID: 7637652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of high- and low-glycemic index energy restricted diets on plasma lipid and glucose profiles in type 2 diabetic subjects with varying glycemic control.
    Heilbronn LK; Noakes M; Clifton PM
    J Am Coll Nutr; 2002 Apr; 21(2):120-7. PubMed ID: 11999539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Subjects with impaired glucose tolerance returned to normal glucose status for six years had lower long-term risk of diabetes: 20 years follow up of Daqing diabetes prevention study].
    Shen XX; Wang JP; Chen YY; An YL; Gong QH; Zhang B; Hong J; Shuai Y; Zhao F; Li H; Li GW
    Zhonghua Nei Ke Za Zhi; 2019 May; 58(5):372-376. PubMed ID: 31060146
    [No Abstract]   [Full Text] [Related]  

  • 39. Relationship of glycosylated hemoglobin to oral glucose tolerance. Implications for diabetes screening.
    Little RR; England JD; Wiedmeyer HM; McKenzie EM; Pettitt DJ; Knowler WC; Goldstein DE
    Diabetes; 1988 Jan; 37(1):60-4. PubMed ID: 3335278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin secretion and insulin sensitivity in Japanese subjects with impaired fasting glucose and isolated fasting hyperglycemia.
    Nishi Y; Fukushima M; Suzuki H; Mitsui R; Ueda N; Taniguchi A; Nakai Y; Kawakita T; Kurose T; Seino Y; Yamada Y
    Diabetes Res Clin Pract; 2005 Oct; 70(1):46-52. PubMed ID: 16126123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.